| scholarly article | Q13442814 |
| P50 | author | Craig A Stockmeier | Q90825100 |
| Grazyna Rajkowska | Q102152110 | ||
| P2860 | cites work | Hippocampal atrophy in recurrent major depression | Q24598190 |
| Increase in serotonin-1A autoreceptors in the midbrain of suicide victims with major depression-postmortem evidence for decreased serotonin activity | Q28116228 | ||
| Morphometry of the dorsal raphe nucleus serotonergic neurons in suicide victims | Q28142835 | ||
| Synaptic pathology in the anterior cingulate cortex in schizophrenia and mood disorders. A review and a Western blot study of synaptophysin, GAP-43 and the complexins | Q28189235 | ||
| Hippocampal apoptosis in major depression is a minor event and absent from subareas at risk for glucocorticoid overexposure | Q28346146 | ||
| Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus | Q29619400 | ||
| Brain Serotonin1A Receptor Binding Measured by Positron Emission Tomography With [11C]WAY-100635 | Q29999635 | ||
| Stress-induced changes in cerebral metabolites, hippocampal volume, and cell proliferation are prevented by antidepressant treatment with tianeptine | Q30531104 | ||
| The importance of a human 3D database and atlas for studies of prefrontal and thalamic functions | Q30620563 | ||
| Impairment of GABAergic transmission in depression: new insights from neuroimaging studies | Q30640044 | ||
| Reduction in Reelin immunoreactivity in hippocampus of subjects with schizophrenia, bipolar disorder and major depression | Q33239430 | ||
| Neural plasticity to stress and antidepressant treatment | Q33772697 | ||
| Disease-specific alterations in frontal cortex brain proteins in schizophrenia, bipolar disorder, and major depressive disorder. The Stanley Neuropathology Consortium | Q33902752 | ||
| Astroglia and glutamate in physiology and pathology: aspects on glutamate transport, glutamate-induced cell swelling and gap-junction communication | Q33919382 | ||
| Neuroimaging studies of mood disorders | Q33924331 | ||
| A serotonin transporter gene promoter polymorphism (5-HTTLPR) and prefrontal cortical binding in major depression and suicide | Q33987746 | ||
| Neuropathological studies of synaptic connectivity in the hippocampal formation in schizophrenia | Q34103967 | ||
| The functional neuroanatomy of the placebo effect | Q34126324 | ||
| High-dimensional mapping of the hippocampus in depression. | Q34167561 | ||
| Oligodendrocyte dysfunction in schizophrenia and bipolar disorder | Q34246905 | ||
| Corticotropin-releasing hormone mRNA levels in the paraventricular nucleus of patients with Alzheimer's disease and depression | Q34303585 | ||
| Course of illness, hippocampal function, and hippocampal volume in major depression | Q34331120 | ||
| The anatomy of mood disorders--review of structural neuroimaging studies | Q34412882 | ||
| Glutamate and GABA systems as targets for novel antidepressant and mood-stabilizing treatments | Q34622392 | ||
| Morphological brain changes in depression: can antidepressants reverse them? | Q34655185 | ||
| The role of corticotropin-releasing hormone in the pathogenesis of Cushing's disease, anorexia nervosa, alcoholism, affective disorders and dementia | Q35237789 | ||
| Glial reduction in the subgenual prefrontal cortex in mood disorders | Q36651128 | ||
| Meta-analyses of studies of ventricular enlargement and cortical sulcal prominence in mood disorders. Comparisons with controls or patients with schizophrenia | Q36691941 | ||
| Basal ganglia-thalamocortical circuits: parallel substrates for motor, oculomotor, "prefrontal" and "limbic" functions | Q37800377 | ||
| Structural abnormalities of subicular dendrites in subjects with schizophrenia and mood disorders: preliminary findings | Q38465336 | ||
| Lithium increases N-acetyl-aspartate in the human brain: in vivo evidence in support of bcl-2's neurotrophic effects? | Q74062508 | ||
| Hippocampal volume in geriatric depression | Q74227453 | ||
| Enhancement of hippocampal neurogenesis by lithium | Q74315939 | ||
| Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication | Q74424004 | ||
| Elevated concentrations of CRF in the locus coeruleus of depressed subjects | Q39394321 | ||
| Relationship of age, age at onset, and sex to depression in older adults | Q40851829 | ||
| Functional neuroanatomy and neuropathology of the human hypothalamus. | Q40917094 | ||
| Decreased dorsolateral prefrontal N-acetyl aspartate in bipolar disorder | Q41724677 | ||
| Reductions in neuronal and glial density characterize the dorsolateral prefrontal cortex in bipolar disorder | Q43593933 | ||
| Changes in regional brain glucose metabolism measured with positron emission tomography after paroxetine treatment of major depression. | Q43625342 | ||
| The density of pyramidal and nonpyramidal neurons in anterior cingulate cortex of schizophrenic and bipolar subjects | Q43744085 | ||
| Anterior cingulate cortex pathology in schizophrenia and bipolar disorder. | Q43768522 | ||
| Neither major depression nor glucocorticoid treatment affects the cellular integrity of the human hippocampus. | Q43892559 | ||
| The density and spatial distribution of GABAergic neurons, labelled using calcium binding proteins, in the anterior cingulate cortex in major depressive disorder, bipolar disorder, and schizophrenia. | Q43923756 | ||
| Localized decrease in serotonin transporter-immunoreactive axons in the prefrontal cortex of depressed subjects committing suicide | Q44130903 | ||
| Low glial numbers in the amygdala in major depressive disorder | Q44145406 | ||
| Dopaminergic abnormalities in amygdaloid nuclei in major depression: a postmortem study | Q44174117 | ||
| Increased corticotropin-releasing hormone immunoreactivity in monoamine-containing pontine nuclei of depressed suicide men. | Q44379299 | ||
| Neuronal pathology in the hippocampal area of patients with bipolar disorder: a study with proton magnetic resonance spectroscopic imaging | Q44438240 | ||
| Altered gene expression of brain-derived neurotrophic factor and receptor tyrosine kinase B in postmortem brain of suicide subjects | Q44545444 | ||
| Reduced neuronal size and glial cell density in area 9 of the dorsolateral prefrontal cortex in subjects with major depressive disorder. | Q47191236 | ||
| Reduced glial cell density and neuronal size in the anterior cingulate cortex in major depressive disorder. | Q47207451 | ||
| Two-dimensional assessment of cytoarchitecture in the anterior cingulate cortex in major depressive disorder, bipolar disorder, and schizophrenia: evidence for decreased neuronal somal size and increased neuronal density | Q47450317 | ||
| Synaptic and plasticity-associated proteins in anterior frontal cortex in severe mental illness | Q48172717 | ||
| Depression duration but not age predicts hippocampal volume loss in medically healthy women with recurrent major depression | Q48188547 | ||
| Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression | Q48208784 | ||
| Lithium treatment causes gliosis and modifies the morphology of hippocampal astrocytes in rats | Q48315144 | ||
| Cortical grey matter reductions associated with treatment-resistant chronic unipolar depression. Controlled magnetic resonance imaging study | Q48342748 | ||
| Morphometric studies of the entorhinal cortex in neuropsychiatric patients and controls: clusters of heterotopically displaced lamina II neurons are not indicative of schizophrenia | Q48366128 | ||
| A reduction of nonpyramidal cells in sector CA2 of schizophrenics and manic depressives | Q48438450 | ||
| Nitric oxide synthase-containing neurons in the human hypothalamus: reduced number of immunoreactive cells in the paraventricular nucleus of depressive patients and schizophrenics | Q48522635 | ||
| Hippocampal changes in patients with a first episode of major depression | Q48564609 | ||
| Reduced levels of norepinephrine transporters in the locus coeruleus in major depression. | Q48617135 | ||
| Subgenual prefrontal cortex abnormalities in mood disorders | Q48725544 | ||
| Electron microscopy of oligodendroglia in severe mental illness. | Q48772850 | ||
| Increased number of vasopressin- and oxytocin-expressing neurons in the paraventricular nucleus of the hypothalamus in depression | Q49151158 | ||
| Localized alterations in pre- and postsynaptic serotonin binding sites in the ventrolateral prefrontal cortex of suicide victims. | Q51046164 | ||
| Hippocampal morphometry in depressed patients and control subjects: relations to anxiety symptoms. | Q51059318 | ||
| Distinction of early- and late-onset depression in the elderly by their lifetime symptomatology. | Q51070597 | ||
| Clinical and phenomenological comparisons of late-onset and early-onset depression. | Q51124752 | ||
| Hippocampal volume reduction in major depression. | Q52172075 | ||
| Cytoarchitectonic Definition of Prefrontal Areas in the Normal Human Cortex: II. Variability in Locations of Areas 9 and 46 and Relationship to the Talairach Coordinate System | Q53641679 | ||
| Hippocampal volume in primary unipolar major depression: a magnetic resonance imaging study. | Q54047414 | ||
| Regional metabolic effects of fluoxetine in major depression: serial changes and relationship to clinical response. | Q55034361 | ||
| Reduced glutamate in the anterior cingulate cortex in depression: an in vivo proton magnetic resonance spectroscopy study | Q57410803 | ||
| Fewer pigmented locus coeruleus neurons in suicide victims: Preliminary results | Q58614294 | ||
| Alterations in the N-methyl-d-asparatate (NMDA) receptor complex in the frontal cortex of suicide victims | Q60473710 | ||
| Prenatal disturbances of nerve cell migration in the entorhinal region: a common vulnerability factor in functional psychoses? | Q70196792 | ||
| Agonist binding to alpha 2-adrenoceptors is elevated in the locus coeruleus from victims of suicide | Q72069857 | ||
| Increased numbers of corticotropin-releasing hormone expressing neurons in the hypothalamic paraventricular nucleus of depressed patients | Q72415584 | ||
| Chronic administration of lithium chloride increases immunodetectable glial fibrillary acidic protein in the rat hippocampus | Q72729067 | ||
| Proliferation of glial cells in vivo induced in the neural lobe of the rat pituitary by lithium | Q73100866 | ||
| Glial fibrillary acidic protein immunoreactivity in the prefrontal cortex distinguishes younger from older adults in major depressive disorder | Q73154099 | ||
| Elevated levels of tyrosine hydroxylase in the locus coeruleus in major depression | Q73178049 | ||
| Quantitative MRI of the hippocampus and amygdala in severe depression | Q73560010 | ||
| P433 | issue | 2 | |
| P921 | main subject | brain tissue | Q11850260 |
| P304 | page(s) | 185-197 | |
| P577 | publication date | 2004-06-01 | |
| P1433 | published in | Dialogues in Clinical Neuroscience | Q24255736 |
| P1476 | title | Cellular abnormalities in depression: evidence from postmortem brain tissue | |
| P478 | volume | 6 |
| Q30371216 | Chronic stress and brain plasticity: Mechanisms underlying adaptive and maladaptive changes and implications for stress-related CNS disorders |
| Q52356865 | Clinical Findings Documenting Cellular and Molecular Abnormalities of Glia in Depressive Disorders. |
| Q37035662 | Early intervention in bipolar disorder, part I: clinical and imaging findings |
| Q33813393 | Hypermethylation in the ZBTB20 gene is associated with major depressive disorder |
| Q26770754 | Neuroinflammation and Depression: Microglia Activation, Extracellular Microvesicles and microRNA Dysregulation |
| Q36126606 | Serotonin-2C and -2a receptor co-expression on cells in the rat medial prefrontal cortex. |
| Q37642802 | The best-laid plans go oft awry: synaptogenic growth factor signaling in neuropsychiatric disease. |
Search more.